clinical trial · NCT06963775
Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials
Ramon Diaz-Arrastia·—·not yet recruiting·n = 215
Traumatic Brain InjuryDelphi-MD device (QuantalX Neuroscience Ltd., Saba Israel)
brief summary
Patients evaluated at Penn Presbyterian Medical Center for traumatic brain injury (TBI), who sign the informed consent, will undergo assessment of electrophysiologic potentials evoked by transcranial magnetic stimulation (TMS), using the Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel).
started
Mar 1, 2026
primary completion
Mar 31, 2030
completion
Jul 31, 2030
last updated
Oct 2, 2025
official title
Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials (TMS-EEG)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol